secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001104659-23-072232
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics enters $125M ATM offering with BofA, terminates Cowen agreement
--------------------------------------------------------------------------------

- Enters Sales Agreement with BofA Securities for at-the-market offering of up to $125M in common stock.
- BofA will receive up to 3.0% of gross proceeds from shares sold under the agreement.
- Prior ATM agreement with Cowen terminated on June 15, 2023; no shares were sold under that agreement.
- Company may sell shares from time to time, with no obligation to sell; can suspend or terminate at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465923072232/0001104659-23-072232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465923072232/tm2318809d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer